Seeking Alpha

Mayo clinic closes study of Geron's Imetelstat to new patients

  • The Mayo Clinic has closed the trial of Geron's (GERN) Imetelstat treatment to new patients after 14 months, although those who are already in the program will continue to receive therapy.
  • The study is evaluating Imetelstat in patients with myelofibrosis and other myeloid malignancies.
  • Geron believes that 79 patients were enrolled in the trial but that 20 have dropped out.
  • Based on preliminary data from the study, Geron intends to start another Phase II trial in H1.
  • Shares are -12.1%; Adam Feuerstein asks on Twitter whether people are "bothered by the 20 patients who dropped out of study?" (8-K)
Comments (8)
  • billeebong
    , contributor
    Comments (178) | Send Message
    ...really. I'd like to see how people panic when a commercial flight closes the door for takeoff. That's all this is but you'd never know it by the market response...
    27 Jan 2014, 08:56 AM Reply Like
  • Sidrico
    , contributor
    Comments (69) | Send Message
    Does AF like anything besides hearing himself talk?
    27 Jan 2014, 09:12 AM Reply Like
  • wecap
    , contributor
    Comments (44) | Send Message
    Adam sucks
    27 Jan 2014, 09:18 AM Reply Like
  • pat walsh
    , contributor
    Comments (286) | Send Message
    AF is just a hack.
    27 Jan 2014, 10:51 AM Reply Like
  • Matija Snuderl
    , contributor
    Comments (282) | Send Message
    I love how all what it takes is a one little tweet from Adam F. and people panic. He must be laughing. I bet he enjoys the power he has over the weak hearts. If imetelstat works on "only" ~75% of patients with myelofibrosis (2o dropped out of ~80), this wil be one of the most remarkable breakthroughs in this disease. So my answer to Adam F. is, no, I am not bothered.
    27 Jan 2014, 10:58 AM Reply Like
  • jeffreyr
    , contributor
    Comment (1) | Send Message
    I'm not bothered at all , emotional traders are silly. Just consider this a buying opportunity for the big players!!!
    27 Jan 2014, 11:47 AM Reply Like
  • User 19606611
    , contributor
    Comment (1) | Send Message
    5 out of 22 (23%) dropping out of the first cohort is roughly the same as 15 dropping out of the next 57 (26%). Seems consistent to me, thus confirming the initial excitement not negating it in my estimation. M.Gold
    27 Jan 2014, 12:18 PM Reply Like
  • chebyshev
    , contributor
    Comments (7) | Send Message
    I have bought 10k today, let Adam tweet more of that.
    27 Jan 2014, 07:38 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs